ETRION SECURES FINANCING FROM MAJOR SHAREHOLDER TO ADVANCE SOLAR PROJECTS IN CHILE September 26, 2013, Geneva, Switzerland – Etrion Corporation (“Etrion” or the “Company”) (TSX: ETX / OMX: ETX), an independent power producer that owns and operates renewable assets, today announced a financing update and investor conference call following recent developments on its solar pipeline in Chile. Financing Update In order to fund Etrion’s current development activities in Chile, the Company has obtained a US$42 million unsecured loan from a company affiliated with Etrion’s largest shareholder, the Lundin family, at an annual interest rate of 12% with a 12-month maturity. The Lundin family loan, along with cash on hand, will be used to develop and build the following previously announced solar projects in Chile: · Project Salvador: a 70 megawatt (“MW”) solar photovoltaic (“PV”) power plant in the Atacama region of Chile that will initially operate on a spot market (“merchant”) basis with revenues based in US dollars and the ability to secure future power purchase agreements (“PPAs”). Project Salvador will be built using SunPower high-efficiency, single-axis tracker technology and will be owned 70% by Etrion, 20% by Total S.A. (“Total”) and 10% by Solventus Energías Renovables (“Solventus”). The total project cost of approximately US$200 million will be financed 70% through US dollar-denominated, non-recourse project debt from the Overseas Private Investment Corporation (“OPIC”) with a 19.5-year tenor. The remaining 30% equity portion will be funded by Etrion, Total and Solventus, based on their respective ownership interests. Construction of Project Salvador is expected to commence by December this year, and the solar project is expected to be operational by the first quarter of 2015 at the latest. · Aguas Blancas: an 8.8 MW solar PV power plant in the Antofagasta region of Chile owned 100% by Etrion. Aguas Blancas will sell electricity through a 15 -year take-or-pay US dollar-denominated PPA with Atacama Minerals Chile S.C.M. The total project cost, including costs related to the licenses, permits, development and construction, is estimated to be US$25 million, a portion of which is expected to be financed through US dollar-denominated, non-recourse project debt with international financial institutions, with the remaining equity portion to be funded by Etrion. Construction of Aguas Blancas is expected to commence in the fourth quarter this year, subject to Etrion arranging the necessary debt financing, and the solar project is expected to be operational in the second quarter of 2014. Once these projects are connected, Etrion is expected to be cash flow positive with a clear path to dividends. These projects will provide a diversified solar power generation platform, in terms of both contract regime and geography, complementing Etrion’s current 60 MW operating platform in Italy and providing counter-seasonal revenues. In connection with the signing of the purchase agreement for Project Salvador, a company affiliated with the Lundin family will have a US$42 million letter of credit issued to Total on behalf of Etrion for total consideration of 2,500,000 common shares in Etrion. As a result, the Lundin family will own 25.4% of the issued and outstanding shares of Etrion directly and through various trusts. As Etrion funds its equity portion of Project Salvador from the Lundin family loan, the availability under the letter of credit will be reduced accordingly. The provision of the Lundin family loan to Etrion and the issuance of common shares to the Lundin family constitute “related party transactions” under Multilateral Instrument 61-101 and are exempt from the minority shareholder approval and valuation requirements, as applicable, under such instrument. Company Comments Ian H. Lundin, the Company’s Chairman, said, “Etrion is a pioneer in securing attractive returns for solar power generation in a non-subsidy environment. Our family has been active in the mining sector in Chile for several years, and we look forward to supplying the industry with clean, renewable energy.” Marco A. Northland, Etrion’s Chief Executive Officer, commented: “We are very fortunate to have such strong support from the Lundin family in order to fund our pipeline. Their vision to see Etrion competitive in a non-subsidy market is becoming a reality with the realization of this project.” Mr. Northland continued, “The next 12 months will be transformational for Etrion as we build and connect our first two projects in Chile, doubling our installed capacity and significantly increasing our cash flow. These projects bring us much closer to our long-term goal of providing an attractive balance of yield and growth to shareholders.” Investor Conference Call Management will host an investor conference call today at 10:00am Eastern Daylight Time (EDT) / 4:00pm Central European Summer Time (CEST) in order to update investors on developments in Chile. Conference call dial-in details: North America: +1-416-340-2216/ Toll Free: +1-866-226-1792 Europe Toll Free: 00-800-9559-6849 Webcast: A webcast will be available at http://www.investorcalendar.com/IC/CEPage.asp?ID=171655. A webcast link and presentation will also be available on the Company’s website at www.etrion.com. A replay of the telephone conference will be available until October 26, 2013. Replay dial-in details: North America: +1-905-694-9451 / Toll Free: +1-800-408-3053 Europe Toll Free: 00-800-3366-3052 Pass code for replay: 5848183 About Etrion Etrion Corporation is an independent power producer that owns and operates renewable assets. The Company currently has approximately 60 MW of operational, ground-based solar photovoltaic power plants in Italy. Etrion is pursuing opportunities in Chile to complement its existing business by developing solar projects with long-term PPAs or at merchant. The Company is listed on the Toronto Stock Exchange in Canada and the NASDAQ OMX Stockholm exchange in Sweden. Etrion’s largest shareholder is the Lundin family, which currently owns 24.5% of the Company’s shares directly and through various trusts. For additional information, please visit the Company’s website at www.etrion.com or contact: Marco A. Northland – Chief Executive Officer Telephone: +41 (22) 715 20 90 Note: The capacity of power plants in this release is described in approximate megawatts on a direct current (“DC”) basis, also referred to as megawatt-peak (“MWp”). Etrion discloses the information provided herein pursuant to the Swedish Securities Market Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication in Sweden at 8:25am Central European Summer Time on September 26, 2013. Forward-Looking Information: This press release contains certain “forward-looking information”. All statements, other than statements of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements relating to the Company’s anticipated plans to build, operate and finance the Project Salvador and Aguas Blancas solar projects, their anticipated construction and operation start dates, the terms and methods under which the projects will be built and operate, the expected impact of the projects on the Company’s operating capacity, cash flows and dividends, and the estimated total cost of each of the projects). This forward-looking information reflects the current expectations or beliefs of the Company based on information currently available to the Company as well as certain assumptions (including that all necessary financing and regulatory or other approvals will be obtained and that the projects will be developed and operated in a manner consistent with Etrion’s expectations). Forward-looking information is subject to a number of significant risks and uncertainties and other factors that may cause the actual results of the Company to differ materially from those discussed in the forward-looking information, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on the Company. Factors that could cause actual results or events to differ materially from current expectations include, but are not limited to, the failure to obtain the necessary financing or approvals to complete construction of the Project Salvador and Aguas Blancas solar projects or to operate them as expected, the failure to satisfy conditions precedent to the transactions as well as unexpected delays in starting or completing the construction of the projects and resulting delays in the start of operations. Any forward-looking information speaks only as of the date on which it is made and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise. Although the Company believes that the assumptions inherent in the forward -looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainty therein.
ETRION FINANCING UPDATE AND INVESTOR CONFERENCE CALL ETRION
Top 10 Most Recent News Articles
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation
Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...
Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight
First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...
Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances
A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...
Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps
Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...
Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight
A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...
Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity
Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...
Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data
Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...
Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal
A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...
Continue Reading
NARUTO Card Game Set for June 2027 Global Launch
Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...
Continue Reading
AI Drives Major Time Savings in Endoscopy Tech
AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...
Continue ReadingTop 5 Most Recently Viewed Articles
Celebrating Culture and Excellence at Clark Capital Management
Clark Capital Management Group Achieves Excellence in Workplace Culture Clark Capital Management Group has once again demonstrated its commitment to creating an outstanding workplace culture. For the seventh consecutive year, the company has been acknowledged by the Philadelphia Business Journal as one of the best places to work in the large-size firm category. This...
Continue Reading
OpenAI Partners with Freedom Holding to Enhance Education in Kazakhstan
OpenAI and Freedom Holding Corp. Join Forces in Kazakhstan The recent partnership between OpenAI, Inc. and Freedom Holding Corp. (NASDAQ: FRHC) marks a transformative moment in Kazakhstan's educational landscape. This strategic agreement paves the way for 165,000 educators across the nation to access ChatGPT Edu, a tailored educational version of ChatGPT, enriched with...
Continue Reading
InnSuites Hospitality Trust Achieves Significant Stock Milestone
InnSuites Hospitality Trust Stock Surges to New Heights In an impressive demonstration of market resilience, InnSuites Hospitality Trust (IHT) has recently achieved a significant milestone, reaching a 52-week high of $2.36. This notable peak signifies more than just a numerical rise; it highlights the confidence and optimism investors have in the hospitality sector's...
Continue Reading
Adrian Kreter's Bold Move with Annanow Enhances Growth Potential
Exciting New Horizons for Annanow with Adrian Kreter's Acquisition In an impressive strategic investment, Swiss technology company Annanow has been fully acquired by entrepreneur Adrian Kreter. This acquisition marks a significant step forward for Annanow as it aspires to reshape its place in the omnichannel technology landscape. With its roots established in 2017,...
Continue Reading
Credit Acceptance Expands Senior Notes Offering to $500 Million
Credit Acceptance Prices $500 Million Senior Notes Offering Credit Acceptance Corporation (Nasdaq: CACC) has announced a significant milestone in its financing strategy, pricing an aggregate principal amount of $500 million for its recently issued 6.625% senior notes due 2030. This offering not only reflects the company’s confidence in its financial future but also...
Continue Reading